The company’s management has guided for 10-15% revenue growth in FY20 and said that costs will be contained. As competitive intensity remains high, Glenmark expects sales in North America to grow in mid-single digits. “With 8% of sales spent on R&D for specialty and innovation, these costs are set to rise till Glenmark finds a suitable minority investor." “Meaningful debt reduction can be achieved if the company is able to generate cash flows through some corporate actions and/or from any large out-licensing deals." But much of the recovery story hinges on asset monetization and debt reduction.

Source: Mint June 02, 2019 16:18 UTC